Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Join/Renew
ASA Community
ASA Home
Code of Conduct
Skip main navigation (Press Enter).
Toggle navigation
Home
About Us
History
Officers
Award Winners
Join
Related Links
Constitution
Meetings
Upcoming Events
Other Local Events
Past Events
News
Discussions
My Signature
My Subscriptions
My Postings
Advanced Search
Post a Message
Our Discussion Group
Library
Our Library
Add a New Entry
Search Library
My Favorites
My Documents
Contact Us
Past Events
2015-
The 3
rd
Annual ASA NJ Chapter/Bayer Statistics Workshop
Evaluating the Validity of Network Meta-Analyses
Meta-analysis of rare events in drug safety studies: An unifying framework for exact inference
A Bayesian hierarchical surrogate outcome model for multiple sclerosis
Integrated Data Analysis for Assessing Treatment Effect through Combining Information from All Sources
ASA NJ Chapter 36
th
Annual Spring Symposium
Reflections on the Opportunities and Challenges of Big Data- Demissie Alemayehu, Pfizer
Taking Biostatistics to New Dimensions- Dhammika Amaratunga, Independent Statistical Consultant, ASA Fellow
Real World Data: How It’s Used at a Medical Device Company- Myoung Kim and Andrew Yoo, J & J
Analytical Approaches for Characterizing the Diffusion of New Medical Technologies- Sharon-Lise Normand, Harvard
Likelihood Ratio-based Tests for Signal Detection from Large Drug Safety Databases- Ram Tiwari, FDA
2014-
The 2
nd
Annual ASA NJ Chapter/Bayer Statistics Workshop
Intention-to-Treat Analysis in Clinical Trials with Treatment Discontinuation and Missing Data-Roderick Little, University of Michigan
Missing Data Sensitivity Analysis of Continuous Endpoint, An Example from a Recent Submission-Arno Fritsch, clinical Statistics Europe, Bayer
Missing Data for Rivaroxaban-Xiang Sun, Janseen Research and Development LLC of J & J
Multiple Imputation Method for Sensitivity Analysis of Time-to-Event Data with Possible Informative Censoring-Yue Zhao, Merck
ASA NJ Chapter 35
th
Annual Spring Symposium
Bayesian Evidence Synthesis in Drug Development and Comparative Effectiveness Research-David Ohlssen, Novartis
Generalizing the MCPMod Methodology beyond Normal, Independent Data-José Pinheiro, Janssen Research & Development
Modeling & Simulation to Improve the Design of Clinical Trials-Gary L. Rosner, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Meta-analysis of Clinical Dose Response in a Large Drug Development Portfolio-N. Thomas, Pfizer
Integration of Knowledge from Late Phase Trials to Support Regulatory Decisions-Yaning Wang, FDA
2013-
Bayer / ASA NJ Chapter Benefit-Risk Workshop
Examining Benefit and Risk Simultaneously at the Individual Patient Level, Christy Chuang-Stein
A Case Study using the BRAT Framework and Quantitative Methods for Benefit-Risk Assessment, Chistoph Dierig
Pragmatic Considerations for Endpoint Selection and Display in Cardiovascular Benefit-Risk Assessment, Bennett Levitan
ASA NJ Chapter Complimentary Symposium on Patient Reported Outcomes
Interpretation of Patient-Reported Outcomes, Joe Cappelleri
The FDA PRO Guidance - Theory and Practice, Ari Gnanasakthy
Current Challenges for Measurement of Treatment Benefits: A PRO Specialist's Perspective, Sue Vallow
ASA NJ Chapter 34
th
Annual Spring Symposium
Are Observational Studies Any Good?, David Madigan
Models for Millions, Robert Stine
A Split-and-Conquer Approach for Analysis of Extremely Large Data, Min-ge Xie
2012-
program
Comparative effectiveness of dynamic treatment regimes, Miguel Hernán
Covariate Balancing Propensity Score, Kosuke Imai
Strategies for Using Partially Valid Instrumental Variables, Dylan Small
Compliance Mixture Modelling with a Zero Effect Complier Class and Missing Data, Michael E. Sobel
Exploring New Statistical Methods for Causal Inference in Longitudinal Studies, Zhiqiang Tan
Skip Navigation Links
Privacy Policy
Code of Conduct
Copyright © 2011 ASA. All rights reserved.
Powered by Higher Logic
×
Community Tags
Add a tag
x
User Tags may not contain the following characters: @ # $ & :